Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,056
Closed -$70.8K 549
2024
Q4
$70.8K Sell
9,056
-867
-9% -$7.14K 0.03% 368
2024
Q3
$73.4K Buy
9,923
+179
+2% +$1.5K 0.03% 422
2024
Q2
$78K Buy
9,744
+1,706
+21% +$15.2K 0.04% 413
2024
Q1
$93.6K Sell
8,038
-550
-6% -$6.09K 0.05% 372
2023
Q4
$95.9K Buy
8,588
+3,969
+86% +$36.5K 0.06% 377
2023
Q3
$71.3K Sell
4,619
-465
-9% -$7.81K 0.04% 382
2023
Q2
$96.3K Buy
+5,084
New +$89.3K 0.06% 403
2021
Q4
Sell
-10,877
Closed -$213K 387
2021
Q3
$213K Sell
10,877
-565
-5% -$10.3K 0.09% 255
2021
Q2
$214K Buy
11,442
+91
+0.8% +$2.03K 0.09% 291
2021
Q1
$269K Buy
11,351
+197
+2% +$4.55K 0.11% 268
2020
Q4
$272K Buy
+11,154
New +$285K 0.11% 266

Other funds holding ETNB

Virtus ETF Advisers's ETNB Position: Q1 2025 in Review

Virtus ETF Advisers sold out of 89bio (ETNB) in Q1 2025, closing a stake of 9,056 shares — an estimated $70.8K sold.

Virtus ETF Advisers first reported a position in ETNB in Q4 2020 and held it in 11 quarters. The position peaked at $272K in Q4 2020. 186 funds tracked by Wall St. Rank hold ETNB as of Q1 2025.

  • Virtus ETF Advisers reported no remaining 89bio position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 9,056 89bio shares in Q1 2025, an estimated $70.8K.
  • Virtus ETF Advisers first reported a position in 89bio in Q4 2020 and held it in 11 quarters.
  • Virtus ETF Advisers's 89bio position peaked at $272K in Q4 2020.
  • 186 funds tracked by Wall St. Rank held 89bio as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.